The thiazolidinediones (TZD) drug pioglitazone is a synthetic ligand that activates the nuclear receptor peroxisome proliferator-activated receptor γ (PPARγ) and is used to treat type 2 diabetes mellitum (DM) for its insulin sensitization effect[8,9]. This evidence concerns the gene PPARG and diabetes mellitus.